Pharmaceutical intermediates
Ipatacopan Hydrochloride Intermediates
6 pharmaceutical intermediates for Ipatacopan Hydrochloride. Indication: Paroxysmal Nocturnal Hemoglobinuria (PNH).
About Ipatacopan Hydrochloride
- Originator
- Novartis Pharmaceuticals Corp
- Indication
- Paroxysmal Nocturnal Hemoglobinuria (PNH)
Available intermediates
6 intermediates currently listed for Ipatacopan Hydrochloride. Request specifications, documentation or a quotation for any item below.
| Product Name | CAS No. | Molecular Formula | Physical Properties |
|---|---|---|---|
| tert-Butyl5-methoxy-7-methyl-1H-indole-1-carboxylate | 1387445-50-2 | / | / |
| tert-Butyl 4-formyl-5-methoxy-7-methyl-1Hindole-1-carboxylate | 1481631-51-9 | / | / |
| tert-butyl 4-formyl-5-hydroxy-7-methyl-1Hindole-1-carboxylate | 2408761-23-7 | / | / |
| 1H-Indole-1-carboxylic acid, 5-hydroxy-7-methyl-, 1,1-dimethylethyl ester | 2408761-22-6 | / | / |
| methyl4-((2S,4S)-4-ethoxypiperidin-2-yl)benzoate | 1644667-61-7 | / | / |
| Benzoic acid, 4-[(2R,4R)-4-ethoxy-2-piperidinyl]-, methyl ester, rel- | 1644667-62-8 | / | / |
Building toward Ipatacopan Hydrochloride?
Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →